Document is current
Any future updates will be listed below
-
Authors
Qiao, Xi https://orcid.org/0000-0002-9795-6644
Routila, Johannes https://orcid.org/0000-0001-5385-7065
Tienhaara, Mari https://orcid.org/0009-0001-9198-082X
Irjala, Heikki https://orcid.org/0000-0003-3054-4677
Santhi, Priyadharshini Parimelazhagan
Huusko, Teemu https://orcid.org/0009-0003-8790-9355
Nissi, Linda
Paatero, Ilkka https://orcid.org/0000-0001-5926-2396
Lehtinen, Noora
Rantala, Juha https://orcid.org/0000-0002-4999-5585
Viljanen, Toni
Leivo, Ilmo
Koivunen, Petri https://orcid.org/0000-0003-4907-3705
Jouppila-Mättö, Anna
Taulu, Rami
Bäck, Leif
Wilkman, Tommy https://orcid.org/0000-0001-5135-478X
Haapio, Eeva https://orcid.org/0000-0002-3349-6829
Kinnunen, Ilpo
Kurppa, Kari https://orcid.org/0000-0001-8286-2429
Westermarck, Jukka https://orcid.org/0000-0001-7478-3018
Ventelä, Sami https://orcid.org/0000-0001-6672-6662
-
Funding
Funding for this research was provided by:
Suomen Lääketieteen Säätiö
Korvatautien Tutkimussäätiö
Jane and Aatos Erkon säätiö
Academy of Finland (354599)
Business Finland (1278/31/2021)
Research Council of Finland’s Flagship InFlames (337530, 357910)
- License Information
-
More Information
Article History
Received: 21 October 2024
Revised: 8 June 2025
Accepted: 16 June 2025
First Online: 17 July 2025
Disclosure and competing interests statement
: The University of Turku has filed a patent covering the diagnostic use of LIMA1 detection on behalf of SV and JW. SV and JW are co-founders and have an ownership interest in Thestra Ltd., developing LIMA1 IHC diagnostics for clinical use.
